Pars plana vitrectomy in the management of ocular toxocariasis


ATABERK H. C.

Retina-Vitreus, cilt.33, sa.2, ss.136-143, 2024 (Scopus) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 33 Sayı: 2
  • Basım Tarihi: 2024
  • Doi Numarası: 10.37845/ret.vit.2024.33.21
  • Dergi Adı: Retina-Vitreus
  • Derginin Tarandığı İndeksler: Scopus, Academic Search Premier, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.136-143
  • Marmara Üniversitesi Adresli: Evet

Özet

Purpose: This study aims to delineate the clinical characteristics, surgical details, and treatment outcomes of patients diagnosed with ocular toxocariasis (OT) who underwent pars plana vitrectomy (PPV). Materials and Methods: A retrospective review of medical records was conducted for patients with OT who underwent PPV at a tertiary uveitis clinic between September 2021 and November 2023. Clinical evaluations, laboratory investigations, treatment modalities, and surgical details were analyzed. A 23-gauge PPV was performed due to persistent vitreous opacity despite medical treatment in all patients. Results: Three pediatric patients with OT were included in this study. All patients presented with vitreous opacity and granuloma at the peripheral retina. Diagnosis relied on characteristic ophthalmologic manifestations and detection of serum or ocular anti-Toxocara antibodies. PPV facilitated the removal of vitreous opacities, traction bands, and inflammatory debris. Silicone oil was used as intraocular tamponade. Postoperatively, visual acuity improved in all cases, with no recurrent inflammation during follow-up. Conclusion: PPV showed promising outcomes in managing OT, leading to significant improvements in visual acuity, resolution of traction bands, and disease stabilization. Further research is required to comprehend the long-term effectiveness and safety of PPV for OT, as well as factors that can predict treatment outcomes.